The predominant flu strain this year is H1N1, which caused the 2009 swine flu pandemic and is now a standard part of the flu ...

AstraZeneca PLC (AZN) has announced a collaboration with Oracle Health and Life Sciences that pairs AstraZeneca’s scientific, clinical-development and regulatory expertise with Oracle’s ...

Late-breaking data from novel cancer vaccines to next-generation KRAS G12C inhibitors and new antibody-drug conjugates will ...

At the European Society of Medical Oncology meeting in Madrid this weekend, analysts will be watching for detailed data on ...

Roche and Teva gained FDA approvals, while Mesa Laboratories and GSK moved ahead with workforce cuts. Strategic moves also took center stage, with Labcorp, AstraZeneca, Galderma and Zealand Pharma ...

Government support, private-public investment, global collaborations and a rich mRNA pipeline create opportunities across vaccines, oncology and personalized medicineDublin, Oct. 16, 2026 (GLOBE ...

According to Zhitong Financial News, AstraZeneca (AZN.US) has announced a collaboration with machine learning biotech company ...

Multiply Labs raised $75 million in Series B financing to scale its robotic manufacturing platform for advanced medicines.

This year’s flu season has arrived about seven weeks earlier than in 2025 or 2024.

The funds will be used to expand the company's robotic platform for manufacturing cell and gene therapies and other biologic ...

Bio / Biotech Weekly Digest for Pharma BD & CVC[Summary of Last Week's Biotech Trends]Last week in the biotech industry was ...